Abstract :

Objective: To measure the levels of adiponectin in women with PCOS having high body mass index.

Methodology: A cross-sectional study including 96 study participants was conducted in Services Hospital, Lahore in December 2020 out of 96 study participants 48 were enrolled as cases having polycystic ovarian syndrome compared with 48 healthy women as controls. Detailed information about age, duration of menstrual cycle, body mass index (BMI), and clinical features like obesity, infertility, acne and hairs on face were noted. A total 5ml venous blood was collected by using aseptic techniques and then centrifuged immediately; serum was separated and stored at -20 °C after proper labeling.  Samples were analyzed for estimation of serum adiponectin by using enzyme linked immunosorbent assay. Statistical analysis was carried out by statistical package for social sciences (SPSS) 21. The p-value < 0.05 was considered to be statistically significant.

Results: In this study level of adiponectin was decreased in PCOS women as compared to healthy women. Mean ± SD of adiponectin in PCOS women was 2.08±0.70µg/ml which was lower than in control group 9.71±5.35µg/ml. Median/Inter Quaitel Range of PCOS women was 2.00/0.78 which is lower in comparison with the Median/IQR of adiponectin in healthy women 8.60/9.63, p-value of   adiponectin was significant (p = 0.00).

Conclusion: Adiponectin is important variable present in circulation. Its levels are changed in response to disease process as occurs in PCOS.

---

Keywords :

Adiponectin, BMI, Healthy women, Polycystic Ovarian Syndrome

---

References :

1. Chenng, P. A., 1990. Polycystic ovary syndrome. Clin Obst Gynae 33: 655-667.
2. Stanely, T., and Misra, M., 2008. Polycystic ovary syndrome in obese adolescents. Opin.Endocrinol.Diabetes.Obes.,15: 30-36 .
3. Dumesic, D. A., Oberfield, S. E., Stener, V. E., Marshall, J. C., Laven, J. S., and Legro, R. S., 2015. Scientific statement on the diagnostic criteria, Epidemiology, pathophysiology and molecular genetics of polycystic ovary syndrome. Rev.36: 487-525.
4. Shayya, R., and Chang, R.J., 2010. Reproductive endocrinology of adolescent polycystic ovary syndrome. J. Gynecol. Obstet.,117.
5. Galic, S., Oakhill, J.S., and Steinberg, G.R., 2010. Adipose tissue as an endocrine organ. Cell.Endocrinol.,316: 129-139.
6. Warner, K. J., and Allscripts, E., 2017. Etiology of polycystic ovarian syndrome. Mayo Clinic, Rochester, Minnesota.
7. Hung, J., Mcquillam, B.M., Thompson, P.L., and Beilby, J.P., 2008. Circulating adiponectin levels associate the inflammatory markers, insulin resistance and metabolic syndrome independent of obesity. J.Obes.,32: 772-779.
8. Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama, K. N., Ezaki, O., Akanuma, Y., Gavrilova, O., Vinson, C., Reitman, M. L., Kagechika, H., Shudo, K., Yoda, M., Nakano, Y., Tobe, K., Nagai, R., Kimura, S., Tomita, M., Froguel, P., and Kadowaki, T., 2001. The fat derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. J.Nat .Med.,7: 941-946.
9. Takahashi , M., Atria, Y.,Yamagata, K.,Matsukawa, Y.,Okutomi, K.,Horie, M.,Shimomura, I.,Hotta, K.,Kuriyama, H.,Kihara, S., Nakamura, T., Yamashita, S.,Funahashi, T., and Matsuzawa,Y., 2000. Genomic structure and mutation in adipose specific gene adiponectin. J.Obes.Rela. Metab.Disord.,24: 861-886.
10. Combs, T. P., Berg, A. H., Rajala, M. W., Klebanov, S., Iyengar, P., and Scherer, P. E., 2003. Sexual differentiation, pregnancy, caloric restriction and aging effect the adipocyte-specific secretory protein adiponectin. Diabetes,52: 268-276.
11. Susan,W., 2010. Adiponectin and Polycystic Ovarian Syndrome. Res.Nurs.,12: 62-72.
12. Meara, N. M., Blackman, J. D., Ehrmann, D. A., Barnes, R. B., Jaspan, J. B., Rosenfield, R. L., and Polonsky, K. S., 1993. Defects in beta cell function in functional ovarian hyperandrogenism. Clin. Endocrinol. Metab.,76:1241-1247.
13. Goodarzi, M. O., Dumesic, D.A., Chazenbalk, G., and Azziz, R., 2011. Polycystic ovary syndrome:etiology, pathogenesis and diagnosis. Rev.Endocrinol.,7: 219-31.
14. Orio, F. J., Palomba, S., and Cascella, T., 2004. Early impairment of endothelial structure and function in young normal-weight women with polycystic ovary syndrome. Clin.Endocrinol.Metab.,89: 4588-4593.
15. Sam, S., and Dunaif, A., 2003. Polycystic ovary syndrome. Trends, Endocrinol, Metab.,14 (8) 365-37.
16. Kojima, S., Funahashi, T., Otsuka, F., Maruyoshi, H., Yamashita, T., and Kajiwara, I., 2002. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction.Atherosclerosis.,194:204.